B. Saeed

发表

Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase.

S. Ng, D. Augeri, P. Kovar, 1999, Bioorganic & medicinal chemistry letters.

Inhibition of farnesyltransferase with A-176120, a novel and potent farnesyl pyrophosphate analogue.

S. Ng, P. Kovar, S. Rosenberg, 2000, European journal of cancer.

Potent inhibitors of protein farnesyltransferase: heteroarenes as cysteine replacements.

S. Ng, P. Kovar, S. Rosenberg, 1999, Bioorganic & medicinal chemistry letters.

Induction of apoptosis in prostatic tumor cell line DU145 by staurosporine, a potent inhibitor of protein kinases

S. Ng, T. Hoang, Haichao Zhang, 1996, The Prostate.

Apoptotic program is initiated but not completed in LNCaP cells in response to growth in charcoal‐stripped media

S. Ng, Haichao Zhang, B. Saeed, 1997, The Prostate.

Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activity.

S. Ng, S. Rosenberg, H. Sham, 1999, Journal of medicinal chemistry.

Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase.

S. Ng, D. Augeri, S. Rosenberg, 1998, Journal of medicinal chemistry.

Second-generation peptidomimetic inhibitors of protein farnesyltransferase demonstrating improved cellular potency and significant in vivo efficacy.

S. Ng, P. Kovar, S. Rosenberg, 1999, Journal of medicinal chemistry.

Endothelin receptor in benign prostatic hyperplastic cells. Binding and functional studies.

S. Magnuson, S. Ng, J. R. Wu-wong, 1997, Receptors & signal transduction.

Combinatorial interaction of human bcl-2 related proteins: mapping of regions important for bcl-2/bcl-x-s interaction.

S. Ng, B. Saeed, H. Zhang, 1995, Biochemical and biophysical research communications.